课题基金 / 基金详情

Pharmaceutical Studies Aiming at Nerve Cell Degeneration Repairing and Protecting Agent

Pharmaceutical Studies Aiming at Nerve Cell Degeneration Repairing and Protecting Agent
神经细胞退变修复保护剂的药学研究
批准号:
12480175
负责人:
FUKUYAMA Yoshiyasu
金额:
$5.25万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2002

项目摘要

项目成果

FUKUYAMA Yoshiyasu的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This research project has been performed toward development of nerve cell degeneration repairing and/or protecting agent from novel neurotrophic natural products. The following results have been obtained.(1) Two types of serum-free primary neuronal cultures have been established. Screening natural products by using these cultured neurons nine new neurite outgrowth promoting active substances and six new neuroprotective substances have been found. One of them, in particular, could protect β-amyloid-induced death of neurons.(2) Neurotrophic substance, honokiol, mastigophorenes A and B, and americanol A and isoamericanol A were synthesized by palladium-catalyzed reactions and/or HRP-catalyzed oxidative coupling. On the other hand, synthesis of plagiochin A was succeeded by intramolecular Stille-Kelly reaction. Now, our effort has directed to the synthesis of merrilactone A based on palladium-catalyzed sequential Stille-Heck reaction.(3) Pharmacological studies on honokiol-induced neurite outgrowth promoting activity were carried out by using several inhibitors. As results, RTK and MAPK signal pathway was indicated to be involved in neurite outgrowth mediated by honokiol. Additionally, Fluo 3 imaging analysis of honokiol showed that it can increase cytoplasmic free Ca^<2+> through a PLC-mediated pathway. It is worthy of note that magnolol, a analog of honokiol, could dose-dependently prevent the decrease of density of the CA1 in the hippocampus of senescence-accelerated mice (SAM).
期刊论文(60)
专著(0)
科研奖励(0)
会议论文
Yoshiyasu Fukuyama et al.: "Merrilactone A, a Novel Neurotrophic Sesquiterpene Dilactone from Illicium merrillianum"Tetrahedron Letters. 41, 32. 6111-6114 (2000)
Yoshiyasu Fukuyama 等人:“Merrilactone A,一种来自八角茴香的新型神经营养倍半萜双内酯”四面体快报。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yoshiyasu Fukuyama: "Vibsane-type Diterpenes from Taiwanese Viburnum odoratissimum"Chem.Pharm.Bull.. 49・2. 242-245 (2001)
Yoshiyasu Fukuyama:“来自台湾荚莲属植物的Vibsane型二萜”Chem.Pharm.Bull.. 49・245 (2001)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yoshiyasu Fukuyama: "The First Total Syhnthesis and Neurotrophic Activitiy of Clusiparalicoline A, a Prenylated and Geranylated Biaryl from Clusia paralicola"Tetrahedron Letters. 43. 6919-6923 (2002)
Yoshiyasu Fukuyama:“Clusiparalicoline A(一种来自 Clusia paralicola 的异戊二烯化和香叶基化联芳基)的首次全合成和神经营养活性”四面体快报。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yoshiyasu Fukuyama et al.: "New Seco-prezizaane-type Sesquiterpenes, Jiadifenin and 1, 2-Dehydroneomajucin with Neurotrophic Activity from Illicium jiadifengpi"J. Nat. Prod.. 65, (4). 527-531 (2002)
Yoshiyasu Fukuyama等人:“来自八角茴香的新型Seco-prezizaane型倍半萜、Jiadifenin和1, 2-DeHydroneomajucin具有神经营养活性”J.
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
30
    Bioorganic Studies on Neurotrophic Natural Products
    • 批准号:
      22590029
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2010
    • 负责人:
      FUKUYAMA Yoshiyasu
    • 依托单位:
    Synthesis of the Selective Nuclear Receptor LXRa Agonist, Riccardins and Development of Anti-arteriosclerosis Drug
    • 批准号:
      18590113
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.56万
    • 财政年份:
      2006
    • 负责人:
      FUKUYAMA Yoshiyasu
    • 依托单位:
    Analysis of Target Molecular and Preparation of Molecular Probes for Neurotrophic Low-Molecular Natural Products
    Chemical Studies toward Development of Nerve Cell Degeneration Repairing or Protecting Agent
    • 批准号:
      09680582
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      1997
    • 负责人:
      FUKUYAMA Yoshiyasu
    • 依托单位: